Skip To Main Content
Zi Ye on Muck Rack

Zi Ye

Irvine
As seen in: Nature, Wiley Online Library, arXiv, PLOS ONE, Frontiers, heart, MDPI, Taylor & Francis Online, Alzheimer's Research and Therapy, Molecular Cancer and
NYU #alumni; PR Specialist with bicultural background. MBA at Redlands

Get in touch with Zi

Contact Zi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Low-temperature liquid-assisted vibrational stress-relief strategy enables stable and efficient perovskite solar cells

|
By Wen Wu, Juntao Guo, Zi Ye, Chenxin Zhang, Tao Cheng, yonghua Chen, Wen-Yong Lai, Peiling Zheng
| Nature Verified
Abstract The commercialization of perovskite photovoltaics is hindered by intrinsic defects and interfacial strain in polycrystalline films, which compromise both efficiency and stability. Conventional chemical passivation is frequently composition- and structure-dependent and introduces heterogeneous impurities that generate additional stress.
Open in Who Shared Issue with article?

Managing electrostatic hazards at the source

|
By Zi Ye, Songkai Liu, Zhinan Zhang
| Nature Verified
Static electricity damages microchips the instant two surfaces touch and separate, long before conventional grounding can drain it away. Worse, the ‘dissipative’ materials meant to prevent this can deposit even more charge. In this Comment, we argue that the fix is to stop the charge at its source, not clear it up afterwards.
Open in Who Shared Issue with article?

HRS-7535, an oral small-molecule GLP-1 receptor agonist, in Chinese adults with obesity without diabetes: a randomized, double-blind, placebo-controlled phase 2 trial

|
By Weijun Gu, Lihui Zhang, Dong Wei, Qifu Li, Zi Ye, Chang Shu, Yiming Mu, Yicen Zong, Tingyan Zhong
| Nature Verified
Abstract HRS-7535 is an orally active small-molecule glucagon-like peptide-1 receptor agonist that showed weight-loss potential in a phase 1 study. In this completed multicenter, randomized, double-blind, placebo-controlled phase 2 trial conducted at 29 centers in China, we evaluated the efficacy and safety of HRS-7535 in adults with obesity without diabetes.
Open in Who Shared Issue with article?
See all 71 licensed articles (73 Total)